Dr Lalchandani Labs Ltd - 541299 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201829-11-2022
29-11-2022
Dr Lalchandani Labs Ltd - 541299 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Arjan LachandaniDesignation :- Managing Director / Whole Time Director23-11-2022
Dr Lalchandani Labs Ltd - 541299 - Unaudited Financial Results For The Half Year Ended September 30, 2022
We are hereby submitting the Unaudited Financial Results along with Limited Review Report for the half year ended on 30th September, 2022. 1. Un-audited Financial Results for the half year ended on 30th September, 2022. 2. Un-audited Statement of Assets and Liabilities for the half year ended on 30th September, 2022. 3. Cash Flow Statement for the half year ended on 30th September, 2022. 4. Limited Review Report for the half year ended 30th September, 2022.14-11-2022
Dr Lalchandani Labs Ltd - 541299 - Board Meeting Outcome for Outcome Of Board Meeting
We are hereby submitting the Unaudited Financial Results along with Limited Review Report for the half year ended on 30th September, 2022. 1. Un-audited Financial Results for the half year ended on 30th September, 2022. 2. Un-audited Statement of Assets and Liabilities for the half year ended on 30th September, 2022. 3. Cash Flow Statement for the half year ended on 30th September, 2022. 4. Limited Review Report for the half year ended 30th September, 2022.14-11-2022
Dr Lalchandani Labs Ltd - 541299 - Board Meeting Intimation for The Board Meeting As Per Regulation 29 Of SEBI(Listing Obligations And Disclosure Requirement) Regulations, 2015
Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we hereby inform that meeting of Board of Directors has been scheduled to be held on Monday, November 14, 2022 to, inter alia, consider and decide the following business matters: 1. To consider and approve Unaudited Financial Results of the Company for the half year ended September 30, 2022 along with the Limited Review Report. 2. Any other Business matter, with the permission of the Chair.10-11-2022
Dr Lalchandani Labs Ltd - 541299 - Closure of Trading Window
Closure of Trading Window Intimation in terms of SEBI(Prohibition of Insider Trading) Regulations, 2015.04-10-2022
Dr Lalchandani Labs Ltd - 541299 - Proceedings At 05Th Annual General Meeting Of The Company Held On 30Th September 2022.
We hereby submit summary of proceedings of the 05th Annual General Meeting of Dr. Lalchandani Labs Limited held on Friday, 30th September 2022 at 03:00 p.m at 1st Floor, 19C, Club Road, Punjabi Bagh West, New Delhi - 11002630-09-2022
Dr Lalchandani Labs Ltd - 541299 - Shareholder Meeting / Postal Ballot-Outcome of AGM
We wish to inform you that the members of the company at their 05th Annual General Meeting held on Friday, 30th September 2022 at 03:00 p.m and concluded at 06:10 p.m at the 1st Floor, 19C, Club Road, Punjabi Bagh West, New Delhi - 110026 have transacted and voted on all the items of business as mentioned in notice of AGM.30-09-2022
Dr Lalchandani Labs Ltd - 541299 - Reg. 34 (1) Annual Report.
Please Find Attached herewith the Annual Report for the Financial Year 2021-2022 of Dr Lalchandani Labs Limited.08-09-2022
Dr Lalchandani Labs Ltd - 541299 - Notice Of 05Th Annual General Meeting
NOTICE is hereby given that the 05th ANNUAL GENERAL MEETING ("AGM") of the Members of Dr Lalchandani Labs Limited will be held on Friday, 30th September 2022 at 03.00 p.m., on the 1st Floor, 19C Club Road, Punjabi Bagh West, New Delhi-110024.,to transact the business as per the notice attached.08-09-2022